Skip to main navigation Skip to search Skip to main content

Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk

Alison V. Grazioli*, Michael E. Plazak, Cynthia S. Shen, Thomas M. Scalea, Rishi Kundi, Ramon A. Riojas, Leonid A. Belyayev

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)660-664
Number of pages5
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume40
Issue number2
DOIs
StatePublished - Feb 2026

Keywords

  • bleeding
  • direct thrombin inhibitors
  • heparin induced thrombocytopenia
  • intravenous immunoglobulin

Cite this